pharmaceutical investing Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor
CHARBONE Announces the Reception of the Main Components at the Sorel-Tracy Site and the Launch of Civil Works
CHARBONE annonce la reception des principales composantes sur le site de Sorel-Tracy et le lancement des travaux civils